Vincent Bondet

8.7k total citations · 1 hit paper
51 papers, 2.0k citations indexed

About

Vincent Bondet is a scholar working on Immunology, Epidemiology and Rheumatology. According to data from OpenAlex, Vincent Bondet has authored 51 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 16 papers in Epidemiology and 14 papers in Rheumatology. Recurrent topics in Vincent Bondet's work include Immune Cell Function and Interaction (11 papers), Systemic Lupus Erythematosus Research (7 papers) and Immunodeficiency and Autoimmune Disorders (7 papers). Vincent Bondet is often cited by papers focused on Immune Cell Function and Interaction (11 papers), Systemic Lupus Erythematosus Research (7 papers) and Immunodeficiency and Autoimmune Disorders (7 papers). Vincent Bondet collaborates with scholars based in France, United Kingdom and United States. Vincent Bondet's co-authors include Claudette Berset, Darragh Duffy, Marie‐Elisabeth Cuvelier, Matthew L. Albert, Jérémy Boussier, Jacques Bellalou, Vincent Mallet, Valérie Paradis, Clémence Hollande and Rosa Barreira da Silva and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and Nature Immunology.

In The Last Decade

Vincent Bondet

49 papers receiving 1.9k citations

Hit Papers

Kinetics and Mechanisms of Antioxidant Activity using the... 1997 2026 2006 2016 1997 250 500 750 1000

Peers

Vincent Bondet
Vincent Bondet
Citations per year, relative to Vincent Bondet Vincent Bondet (= 1×) peers Francesca Aiello

Countries citing papers authored by Vincent Bondet

Since Specialization
Citations

This map shows the geographic impact of Vincent Bondet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Bondet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Bondet more than expected).

Fields of papers citing papers by Vincent Bondet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Bondet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Bondet. The network helps show where Vincent Bondet may publish in the future.

Co-authorship network of co-authors of Vincent Bondet

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Bondet. A scholar is included among the top collaborators of Vincent Bondet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Bondet. Vincent Bondet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saidoune, Fanny, Danyel Lee, Jérémy Di Domizio, et al.. (2025). Enhanced TLR7-dependent production of type I interferon by pDCs underlies pandemic chilblains. The Journal of Experimental Medicine. 222(7). 3 indexed citations
2.
Bader‐Meunier, Brigitte, T. Moreau, Florence A. Aeschlimann, et al.. (2025). Myositis-specific autoantibody subtypes are associated with response to Janus kinase inhibitors in patients with juvenile dermatomyositis. Lara D. Veeken. 64(10). 5487–5492. 1 indexed citations
3.
Fournier, Benjamin, Jamie Sugrue, Thomas Moreau, et al.. (2025). Dazukibart for the treatment of severe TIF1γ ‐positive juvenile dermatomyositis. Journal of the European Academy of Dermatology and Venereology. 40(4). e189–e192.
4.
Cooles, Faye A. H., Najib Naamane, Arthur G. Pratt, et al.. (2024). Endogenous Retroelement Activation is Implicated in Interferon‐α Production and Anti–Cyclic Citrullinated Peptide Autoantibody Generation in Early Rheumatoid Arthritis. Arthritis & Rheumatology. 77(6). 646–657. 1 indexed citations
5.
Haljasmägi, Liis, Madhvi Menon, Thomas McDonnell, et al.. (2023). Inactive disease in patients with lupus is linked to autoantibodies to type I interferons that normalize blood IFNα and B cell subsets. Cell Reports Medicine. 4(1). 100894–100894. 26 indexed citations
6.
Gonçalves, Pedro, Jean‐Marc Doisne, Bruno Charbit, et al.. (2022). Defects in mucosal immunity and nasopharyngeal dysbiosis in HSC-transplanted SCID patients with IL2RG/JAK3 deficiency. Blood. 139(17). 2585–2600. 4 indexed citations
7.
Rodero, Mathieu P., Florence A. Aeschlimann, François‐Jérôme Authier, et al.. (2022). Efficacy and tolerance of corticosteroids and methotrexate in patients with juvenile dermatomyositis: a retrospective cohort study. Lara D. Veeken. 61(11). 4514–4520. 3 indexed citations
8.
Hau, Annika, Vincent Bondet, Darragh Duffy, et al.. (2022). Activation of NLRP3 Inflammasome in the Skin of Patients with Systemic and Cutaneous Lupus Erythematosus. Acta Dermato Venereologica. 102. adv00708–adv00708. 15 indexed citations
9.
Voyer, Tom Le, Cyril Gitiaux, François‐Jérôme Authier, et al.. (2021). JAK inhibitors are effective in a subset of patients with juvenile dermatomyositis: a monocentric retrospective study. Lara D. Veeken. 60(12). 5801–5808. 54 indexed citations
10.
Bondet, Vincent, Sophie Le Poder, Alexis Lécu, et al.. (2021). Constitutive IFNα Protein Production in Bats. Frontiers in Immunology. 12. 735866–735866. 13 indexed citations
11.
Courties, Alice, Jérémy Boussier, Jérôme Hadjadj, et al.. (2021). Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patients. Scientific Reports. 11(1). 11886–11886. 31 indexed citations
12.
Dufort, Matthew J., Alba Llibre, Cate Speake, et al.. (2020). Innate immune stimulation of whole blood reveals IFN-1 hyper-responsiveness in type 1 diabetes. Diabetologia. 63(8). 1576–1587. 25 indexed citations
13.
Scagnolari, Carolina, Federica Frasca, Nikaïa Smith, et al.. (2020). Decreased Type I Interferon Production by Plasmacytoid Dendritic Cells Contributes to Severe Dengue. Frontiers in Immunology. 11. 605087–605087. 14 indexed citations
14.
Reynolds, John A., Tracy A. Briggs, Gillian Rice, et al.. (2019). Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profiles. Arthritis Research & Therapy. 21(1). 147–147. 19 indexed citations
15.
Palucci, Ivana, Basem Battah, Flavio De Maio, et al.. (2019). IP-10 contributes to the inhibition of mycobacterial growth in an ex vivo whole blood assay. International Journal of Medical Microbiology. 309(5). 299–306. 14 indexed citations
16.
Truffault, Frédérique, Vincent Bondet, Darragh Duffy, et al.. (2019). Risk factors associated with myasthenia gravis in thymoma patients: The potential role of thymic germinal centers. Journal of Autoimmunity. 106. 102337–102337. 42 indexed citations
17.
Llibre, Alba, Nicole Bilek, Vincent Bondet, et al.. (2019). Plasma Type I IFN Protein Concentrations in Human Tuberculosis. Frontiers in Cellular and Infection Microbiology. 9. 296–296. 11 indexed citations
18.
Frémond, Marie‐Louise, Marie Legendre, Michaël Fayon, et al.. (2019). Use of ruxolitinib in COPA syndrome manifesting as life-threatening alveolar haemorrhage. Thorax. 75(1). 92–95. 38 indexed citations
19.
Aeschlimann, Florence A., Marie‐Louise Frémond, Darragh Duffy, et al.. (2018). A child with severe juvenile dermatomyositis treated with ruxolitinib. Journal of Financial Econometrics. 5 indexed citations
20.
Llibre, Alba, Vincent Bondet, Mathieu P. Rodero, et al.. (2018). Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α. Journal of Visualized Experiments. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026